I'm not blaming clinicians. I'm blaming RAP management. How you can have 99% results and <50% is beyond me. Either they had unrealistically high numbers in Australia or thetly stuffed up the study procedure in the US. Management are to blame in both cases for the botch up.
- Forums
- ASX - By Stock
- RAP
- Ann: Preliminary Top-line Results from SMARTCOUGH-C Study
Ann: Preliminary Top-line Results from SMARTCOUGH-C Study, page-56
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
-
- There are more pages in this discussion • 354 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
The Watchlist
LPM
LITHIUM PLUS MINERALS LTD.
Simon Kidston, Non--Executive Director
Simon Kidston
Non--Executive Director
SPONSORED BY The Market Online